Siga Technologies Inc. (NASDAQ:SIGA – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Traders acquired 1,200 call options on the company. This is an increase of approximately 1,438% compared to the average volume of 78 call options.
Siga Technologies Stock Performance
Shares of NASDAQ:SIGA opened at $6.66 on Thursday. Siga Technologies has a 52 week low of $4.95 and a 52 week high of $9.62. The firm has a market cap of $476.93 million, a PE ratio of 6.53 and a beta of 0.98. The firm’s fifty day moving average is $6.27 and its 200-day moving average is $7.46.
Siga Technologies (NASDAQ:SIGA – Get Free Report) last posted its quarterly earnings data on Thursday, November 6th. The company reported ($0.09) earnings per share for the quarter. The company had revenue of $2.62 million during the quarter. Siga Technologies had a net margin of 43.22% and a return on equity of 35.23%. Sell-side analysts forecast that Siga Technologies will post 1.04 EPS for the current year.
Analyst Upgrades and Downgrades
Check Out Our Latest Analysis on SIGA
Hedge Funds Weigh In On Siga Technologies
Hedge funds have recently made changes to their positions in the stock. BNP Paribas Financial Markets lifted its stake in shares of Siga Technologies by 34.1% in the second quarter. BNP Paribas Financial Markets now owns 4,661 shares of the company’s stock worth $30,000 after acquiring an additional 1,184 shares during the period. DekaBank Deutsche Girozentrale acquired a new stake in Siga Technologies during the 2nd quarter valued at approximately $34,000. State of Alaska Department of Revenue bought a new position in Siga Technologies during the 3rd quarter worth approximately $34,000. Tower Research Capital LLC TRC raised its holdings in Siga Technologies by 116.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 6,817 shares of the company’s stock worth $44,000 after purchasing an additional 3,669 shares during the last quarter. Finally, Bailard Inc. acquired a new position in shares of Siga Technologies in the 2nd quarter worth approximately $78,000. 55.40% of the stock is currently owned by institutional investors.
Siga Technologies Company Profile
Siga Technologies, Inc (NASDAQ: SIGA) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of medical countermeasures for public health emergencies and biological threats. The company’s flagship product, TPOXX® (tecovirimat), is the first and only antiviral approved by the U.S. Food and Drug Administration for the treatment of smallpox. Siga has entered into procurement and development contracts with U.S. government agencies, including the Biomedical Advanced Research and Development Authority (BARDA) and the Department of Defense, to supply TPOXX® for the Strategic National Stockpile.
Founded in 2002, Siga has built a pipeline of therapies targeting high-consequence pathogens such as smallpox, plague and other potential biothreat agents.
Featured Stories
- Five stocks we like better than Siga Technologies
- A month before the crash
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Wall Street Alert: Buy AES
- Bitcoin is down but your income is about to explode
- Trump Devises the Death of the IRS ☠️
Receive News & Ratings for Siga Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siga Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
